Inventor · disambiguated record
Jong Chan Son
Also filed as: SON JONG C · SON JONG CHAN
8 granted patents·2 pending applications·45 citations·filing 1994–2017
84Inventor score
Files withKOREA RES INST CHEM TECH4GUO HONGYAN3KOREA RES INST CHEMICAL TECH1KOREA RES INST OF CHEM TECH1ST PHARM CO LTD1
Top patents by PatentIndex Score
10 records- 0186US8106064B2Pyrimidine-2,4-dione HIV reverse transcriptase inhibitorsGUO HONGYAN·Filed 2007·Granted Jan 31, 2012·6 cites·36 claims
- 0280US8334295B2Pyrimidine derivatives as HIV reverse transcriptase inhibitorsGUO HONGYAN·Filed 2008·Granted Dec 18, 2012·4 cites·2 claims
- 0375US9499537B2Antiviral pyrrolopyridine derivatives and method for preparing the sameKOREA RES INST CHEMICAL TECH·Filed 2014·Granted Nov 22, 2016·3 cites·19 claims
- 0473US6713486B1Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereofKOREA RES INST CHEM TECH·Filed 2000·Granted Mar 30, 2004·10 cites·6 claims
- 0568US5747500AAntiviral 2, 4-pyrimidinedione derivativesKOREA RES INST CHEM TECH·Filed 1994·Granted May 5, 1998·14 cites·5 claims
- 0655US2011184029A1Pyridone derivatives as non-nucleoside reverse transcriptase inhibitorsKOREA RES INST CHEM TECH·Filed 2009·Application pending·0 cites
- 0751US8119800B2Processes for preparing HIV reverse transcriptase inhibitorsGUO HONGYAN·Filed 2008·Granted Feb 21, 2012·0 cites·23 claims
- 0850US6136815AAntiviral 2,4-pyrimidinedione derivatives and process for the preparation thereofKOREA RES INST OF CHEM TECH·Filed 1997·Granted Oct 24, 2000·8 cites·8 claims
- 0948US2013078256A1Novel hiv reverse transcriptase inhibitorsKOREA RES INST CHEM TECH·Filed 2012·Application pending·0 cites
- 1041US11214570B2Pyrrolopyridine derivative, method for producing same, and use thereofST PHARM CO LTD·Filed 2017·Granted Jan 4, 2022·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Jong Chan Son files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →